May is Hepatitis Awareness Month and May 19th marks the 8th annual Hepatitis Testing Day in the U.S.! Organizations around the U.S. are out and about spreading awareness about hepatitis B and hosting many hepatitis education and testing events. We are excited to share resources of opportunities for everyone to get involved in their community this month and throughout the year.
Finally, join Join Hepatitis B Foundation, NASTAD and CDC’s Division of Viral Hepatitis for a Twitter HepChat at 2 p.m. (ET) Thursday, June 13th. The chat will highlight Hepatitis Awareness Month outreach events and allow partner organizations to share their successes, challenges and lessons learned from their efforts. Keep us posted with your events throughout the month with the hashtag #Hepaware19 and remember to join the Twitter Chat conversation with the hashtag #HepChat19.
If I am infected, can I safely breastfeed my baby?
What is the hepatitis B vaccine schedule?
We will tackle some of these questions, myths about hepatitis B transmission, and how to address common misconceptions. Join a conversation with our panelists and share your own questions about hepatitis B transmission and prevention.
Please join Hep B United on Wednesday, January 23, 2019 at 3:00 pm EST for a webinar to learn about tools and resources to support the global elimination of hepatitis B. Globally, an estimated 292 million are living with chronic hepatitis B infection, yet only 10% are diagnosed. Additionally, out of the estimated 94 million eligible for treatment, of these, only 4.8 million or 5% were treated. Join us for this interactive session to learn about novel initiatives to expand epidemiological data through the Polaris Observatory and resources to increase access to hepatitis screening and treatment.
Join us for a Webinar: Hepatitis Delta: Current and Future Treatments Tuesday, January 8th 2019 7:00 AM PT / 10:00 AM ET
While scientific advancements in the last 20 years have brought highly effective treatment options for hepatitis B patients; treatments for hepatitis B and delta coinfected patients have lagged behind. Interferon therapy remains the only somewhat effective treatment option for 15-20 million patients who are anxiously awaiting new drugs to control their coinfection. With 7 new drugs in clinical trials, there is hope.
Join professor Cihan Yurdaydin, MD, secretary general for the World Gastroenterology Organization and Educational Councilor of EASL, for an in-depth perspective on current treatment regimens for hepatitis delta and a look at new drugs in the pipeline that show promise for more effective future treatments.
Register here – even if you cannot attend live, please register and we will email you the webinar recording!
Join Hep B United on Monday, December 3rd at 3:00 pm Eastern Time for updates on hepatitis B policy and advocacy! Learn about hepatitis B and liver cancer-related legislation, recent policy changes, new resources, and opportunities to get involved in hepatitis B advocacy in 2019.
In the U.S., up to 2 million people are living with chronic hepatitis B infection, only 25 percent are aware of their infection, and less than 10 percent of infected individuals are able to access care and receive treatment. Among those chronically infected with hepatitis B, an estimated 70 percent are non-U.S. born and face unique barriers in accessing health care services.
Join this session to learn about three hepatitis B testing and linkage to care programs funded by the Centers for Disease Control and Prevention (CDC) in 2014 to 2017. Panelists from Chicago, Livingston, New Jersey/New York City, and Sacramento will share innovative strategies and partnerships to improve testing and linkage to care among high-risk populations, including patient navigation programs, using electronic medical records, and educating health care providers.
WASHINGTON, D.C. (July 2018) – Hep B United, a national coalition established by the Hepatitis B Foundation (HBF) and the Association of Asian Pacific Community Health Organizations (AAPCHO) to address the silent epidemic of hepatitis B, will host its sixth annual summit in Washington, D.C., July 24 to 26. The summit brings together community leaders, advocates and people with hepatitis B to promote screening and prevention strategies and advocate for equitable access to health care to further its mission to eliminate hepatitis B in the United States.
Hepatitis B is caused by a virus and is the world’s most common, serious liver infection. It is also the deadliest vaccine-preventable disease, with nearly 1 million people dying each year from hepatitis B-related disease worldwide. In the United States, up to 2.2 million Americans are chronically infected with hepatitis B, yet most do not know it. Without early diagnosis and intervention, one in four people living with hepatitis B will die prematurely from liver failure or liver cancer.
Continue reading Hepatitis B Leaders Call for the Elimination of Hepatitis B →
The annual Hep B United Summit, organized by the Hepatitis B Foundation, convenes in Washington D.C. from Wednesday, July 25 through Thursday, July 26. National and local coalition partners, experts, stakeholders, and federal partners will meet to discuss how to increase hepatitis B testing and vaccination and improve access to care and treatment for individuals living with hepatitis B.
You can watch many of these sessions on Facebook Live. You can also follow the conversation at the Summit on Twitter with #Hepbunite!
Facebook Live is live video streaming available to all Pages and profiles on Facebook. Check out the agenda below and go to the HepBUnited Facebook Page to view the live broadcast. Some breakout sessions may be broadcast from the Hepatitis B Foundation Facebook Page. Sessions will also be available following the broadcast for those who are not able to join us live.
Continue reading Join the Conversation at the Hep B United Summit; Watch Summit Sessions On Facebook Live →